Royal Bank of Canada’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.74M | Buy |
|
|||||
|
2025
Q1 | $206K | Sell |
|
|||||
|
2024
Q4 | $439K | Sell |
|
|||||
|
2024
Q3 | $2.35M | Sell |
|
|||||
|
2024
Q2 | $2.57M | Sell |
|
|||||
|
2024
Q1 | $3.17M | Sell |
|
|||||
|
2023
Q4 | $4.68M | Buy |
|
|||||
|
2023
Q3 | $2.64M | Buy |
|
|||||
|
2023
Q2 | $1.35M | Buy |
|
|||||
|
2023
Q1 | $1.04M | Sell |
|
|||||
|
2022
Q4 | $1.26M | Buy |
|
|||||
|
2022
Q3 | $1.07M | Sell |
|
|||||
|
2022
Q2 | $1.05M | Sell |
|
|||||
|
2022
Q1 | $2.23M | Sell |
|
|||||
|
2021
Q4 | $3.77M | Buy |
|
|||||
|
2021
Q3 | $3.18M | Buy |
|
|||||
|
2021
Q2 | $3.65M | Sell |
|
|||||
|
2021
Q1 | $1.93M | Sell |
|
|||||
|
2020
Q4 | $6.86M | Buy |
|
|||||
|
2020
Q3 | $2.5M | Sell |
|
|||||
|
2020
Q2 | $2.68M | Buy |
|
|||||
|
2020
Q1 | $1.46M | Sell |
|
|||||
|
2019
Q4 | $1.82M | Sell |
|
|||||
|
2019
Q3 | $1.76M | Sell |
|
|||||
|
2019
Q2 | $2.19M | Buy |
|
|||||
|
2019
Q1 | $604K | Buy |
|
|||||
|
2018
Q4 | $442K | Sell |
|
|||||
|
2018
Q3 | $1.1M | Sell |
|
|||||
|
2018
Q2 | $1.06M | Buy |
|
|||||
|
2018
Q1 | $640K | Buy |
|
|||||
|
2017
Q4 | $93K | Sell |
|
|||||
|
2017
Q3 | $159K | Buy |
|
|||||
|
2017
Q2 | $91K | Buy |
|
|||||
|
2017
Q1 | $61K | Sell |
|
|||||
|
2016
Q4 | $117K | Buy |
|
|||||
|
2016
Q3 | $136K | Buy |
|